Business Context and Reporting Period
Company: Aligos Therapeutics, Inc. (ALGS)
Filing Type: Form 8-K (Current Report)
Date of Report: September 10, 2026
Event: Entry into a Material Definitive Agreement (First Amendment to Lease) for the Company's headquarters located at One Corporate Drive, South San Francisco, CA.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, or general liquidity metrics. It details specific lease financial obligations:
- Lease Term Extension: Extended from March 31, 2027, to March 31, 2034.
- Rent Abatement: Ten months of rent abatement from April 1, 2027, to January 31, 2028 (contingent on no material default).
- Termination Consideration: A one-time option to terminate on March 31, 2031, requires a payment of $2,476,429.22.
- Escalation Schedule: Base monthly rent per square foot increases annually from $4.650 (2027-2028) to $5.716 (2033-2034).
Material Changes Versus Prior Period
The filing outlines a material change to the Company's existing lease agreement dated June 21, 2018:
- Term Extension: The lease term is extended by seven years beyond the original expiration date.
- Extension Option Revision: The existing extension option was revised from one eight-year option to one seven-year option.
- New Termination Rights: Added a specific termination option in 2031 with a defined fee and a penalty-free termination right if the Company relocates to a larger space (minimum 60,000 sq. ft.) within the Landlord's portfolio.
Guidance, Outlook, and Risks
Management Commentary: The filing provides no forward-looking financial guidance or strategic outlook beyond the lease terms.
Risks and Contingencies:
- Abatement Condition: The ten-month rent abatement is conditional upon the Company not being in material default under the Lease.
- Termination Costs: Exercising the 2031 termination option requires a significant cash outlay of approximately $2.48 million.
- Expense Obligations: The Company remains obligated to pay a specified percentage of certain expenses paid by the Landlord.
Investor Verification Checklist
- Verify the total square footage of the leased space to calculate total annual rent obligations based on the per-square-foot rates provided.
- Review the upcoming Form 10-Q for the quarter ending September 30, 2026, for the full text of the First Amendment.
- Assess the Company's current cash position against the potential $2,476,429.22 termination fee if the 2031 exit option is considered.
- Confirm the definition of "material default" in the lease to understand the risk to the rent abatement.